Overexpression of serum MicroRNA-140-3p in premenopausal women with newly diagnosed breast cancer

Publish Year: 1397
نوع سند: مقاله کنفرانسی
زبان: English
View: 464

نسخه کامل این Paper ارائه نشده است و در دسترس نمی باشد

  • Certificate
  • من نویسنده این مقاله هستم

این Paper در بخشهای موضوعی زیر دسته بندی شده است:

استخراج به نرم افزارهای پژوهشی:

لینک ثابت به این Paper:

شناسه ملی سند علمی:

ICBCMED14_004

تاریخ نمایه سازی: 21 مرداد 1398

Abstract:

Introduction &Aims: The purpose of the present study was to evaluate microRNA-140-3p expression level in breast cancer patients in comparison to healthy controls.Methods: Serum microRNA-140-3p level was quantified by real-time quantitative reverse transcription PCR in 40 women with breast cancer and 40 healthy subjects.Results: Serum microRNA-140-3p level in patients compared to healthy subjects was significantly up-regulated (p=0.01). MicroRNA-140-3p had a good diagnostic accuracy for discrimination of the two groups (AUC=0.667; sensitivity=70%; specificity=50%). Serum microRNA-140-3p level was overexpressed in premenopausal patients who were ≤48 years old. ROC curve showed a similar pattern again (AUC=0.690; sensitivity=73%; specificity=50%). Conclusions: microRNA-140-3p has the potential for detection of breast cancer, especially in premenopausal (≤48years old) women.

Authors

Nadia Heydari

Student Research Committee, Babol University of Medical Sciences, Babol, Iran,

Novin Nikbakhsh

Cancer Research Center, Babol University of Medical Sciences, Babol, Iran,

Farzin Sadeghi

Cellular and Molecular Biology Research Center, Health Research Institute, Babol University of Medical Sciences, Babol, Iran,

Nazila Farnoush

Department of Surgery, Babol University of Medical Sciences, Babol, Iran,